|

Dolutegravir (DTG) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Carlos Brites1

Indications

  • Neuritis1
  • HTLV I Associated T Cell Leukemia Lymphoma1
  • HTLV I Associated Myelopathies1
  • HTLV-1 Infection1
  • Cancer1

Other1 trial

Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.